Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease

被引：0
|
作者：
Fang-Ping Ren
Qi Chen
Shan-Shan Yao
Lin Feng
Xin-Ying Xue
Wei-Chao Zhao
Dong Wang
Zhi-Ling Zhao
Si-Wei Gu
Ting Li
Ya-Wen Shen
Lan Gao
Xue-Lei Zang
Xin-Yu Bao
Zhao-Hui Tong
机构：
[1] Beijing Shijitan Hospital,
[2] Capital Medical University,undefined
[3] University of Pittsburgh,undefined
[4] Beijing Chao-Yang Hospital,undefined
[5] Capital Medical University,undefined
[6] PLA Strategic Support Force Medical Center,undefined
[7] Xuanwu Hospital,undefined
[8] Capital Medical University,undefined
[9] Weifang Medical College,undefined
来源：
BMC Pulmonary Medicine | / 23卷
关键词：
Anti-melanoma differentiation-associated gene 5; Dermatomyositis; Interstitial lung disease; Lymphocyte subsets; Prognostic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis
    Sakamoto, Noriho
    Ishimoto, Hiroshi
    Nakashima, Shota
    Yura, Hirokazu
    Miyamura, Takuto
    Okuno, Daisuke
    Hara, Atsuko
    Kitazaki, Takeshi
    Kakugawa, Tomoyuki
    Ishimatsu, Yuji
    Satoh, Minoru
    Mukae, Hiroshi
    INTERNAL MEDICINE, 2019, 58 (06) : 837 - 841
  • [32] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    So, Ho
    Wong, Victor Tak Lung
    Lao, Virginia Weng Nga
    Pang, Hin Ting
    Yip, Ronald Man Lung
    CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1983 - 1989
  • [33] Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis
    Yoshinao Muro
    Kazumitsu Sugiura
    Masashi Akiyama
    Clinical Rheumatology, 2013, 32 : 395 - 398
  • [34] Disease Trajectory in anti-MDA5 Dermatomyositis Patients Presented with Different Stage of Interstitial Lung Disease
    Lan, Ting-Yuan
    Lee, Tai-Ju
    Chang, Ting-Wei
    Cheng, Chiao-Feng
    Shen, Chieh-Yu
    Lu, Cheng-Hsun
    Lin, Kuan-Yen
    Hsieh, Song-Chou
    Li, Ko-Jen
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2327 - 2328
  • [35] Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease
    Li, Liubing
    Wang, Qian
    Wen, Xiaoting
    Liu, Chenxi
    Wu, Chanyuan
    Yang, Funing
    Zeng, Xiaofeng
    Li, Yongzhe
    ONCOTARGET, 2017, 8 (44) : 76129 - 76140
  • [36] Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis
    Muro, Yoshinao
    Sugiura, Kazumitsu
    Akiyama, Masashi
    CLINICAL RHEUMATOLOGY, 2013, 32 (03) : 395 - 398
  • [37] Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis
    Li, Liubing
    Wang, Qian
    Yang, Funing
    Wu, Chanyuan
    Chen, Si
    Wen, Xiaoting
    Liu, Chenxi
    Li, Yongzhe
    ONCOTARGET, 2017, 8 (16) : 26552 - 26564
  • [38] Anti-MDA5-Antibody Is Not Prognostic Markerin the Chronic Phase of Interstitial Lung Disease in Patients with Dermatomyositis
    Sakamoto, S.
    Okamoto, M.
    Kaieda, S.
    Nakamura, M.
    Nouno, T.
    Koga, T.
    Tominaga, M.
    Kawayama, T.
    Kuwana, M.
    Ida, H.
    Hoshino, T.
    Fujimoto, K.
    Nagata, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [39] Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib
    Natoli, Valentina
    Palmeri, Serena
    Rebollo-Gimenez, Ana Isabel
    Matucci-Cerinic, Caterina
    Bocca, Paola
    Caorsi, Roberta
    Volpi, Stefano
    Papa, Riccardo
    Consolaro, Alessandro
    Gattorno, Marco
    Ravelli, Angelo
    Rosina, Silvia
    PEDIATRIC RHEUMATOLOGY, 2025, 23 (01)
  • [40] Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model
    Wang, Lei
    Lv, Chengyin
    You, Hanxiao
    Xu, Lingxiao
    Yuan, Fenghong
    Li, Ju
    Wu, Min
    Zhou, Shiliang
    Da, Zhanyun
    Qian, Jie
    Wei, Hua
    Yan, Wei
    Zhou, Lei
    Wang, Yan
    Yin, Songlou
    Zhou, Dongmei
    Wu, Jian
    Lu, Yan
    Su, Dinglei
    Liu, Zhichun
    Liu, Lin
    Ma, Longxin
    Xu, Xiaoyan
    Zang, Yinshan
    Liu, Huijie
    Ren, Tianli
    Liu, Jin
    Wang, Fang
    Zhang, Miaojia
    Tan, Wenfeng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345